Company profile
The company is a high-tech enterprise focusing on the research, development, production and sales of veterinary drugs, covering many fields such as veterinary premixtures, veterinary APIs, food preservatives and so on. the production products include bacitracin products, colistin sulfate products, natamycin food preservatives and so on. At present, the company's main products are bacitracin products, which mainly include bacitracin zinc premixture (BZN) and methylene salicylate bacitracin premixture (MDAB), which are used in downstream animal husbandry and breeding industry in the form of drug feed additive, which plays a good role in promoting livestock and poultry growth and preventing animal intestinal diseases. The company has mature experience in the field of microbial fermentation and is one of the main producers and exporters of bacitracin products in China. The company is one of the few enterprises in the world that have passed the on-site audit of FDA in the United States.
The highlight of the company
The main results are as follows: (1) the company has mastered the core technology of production process, such as spray drying technology, wet granulation technology, microbial fermentation control technology and strain selection technology. The company's bacitracin products and colistin sulfate products are in line with the standards of Chinese Veterinary Pharmacopoeia, American Pharmacopoeia and European Pharmacopoeia. The company's strong technical strength can not only improve the existing production process level and product quality, but also carry out product research and development according to market demand. Through continuous technological innovation, the company ensures the technological leading position of its products.
(2) the company attaches great importance to product quality, organizes production in strict accordance with veterinary drug GMP standards and other laws and regulations, establishes a complete quality control system, and strictly implements the production operation standards in the actual production process. Through the continuous improvement of the production process, the company has mastered the core technology of fermentation, and the product quality stability is good, ensuring the company's leading quality advantage in the industry. Relying on the advantage of quality, the company sells its products to South America, North America, Southeast Asia and other regions. Its reliable product quality has won the trust of the majority of customers and laid a good customer foundation for the company to further expand sales. The company's products have a high level of quality, and the main products have passed the veterinary drug GMP management certification of the Ministry of Agriculture of China, in which methylene salicylate cecropin has passed the FDA on-site audit of the United States, and BZN, MDAB and LNY have passed the GMP management certification of Australia.
(3) the company's high brand awareness not only improves customer trust and promotes the smooth development of bilateral cooperation, but also lays a good brand foundation for the market promotion of new products and ensures the construction and expansion of marketing network at home and abroad. At present, the company has established stable cooperative relations with customers such as Shuoteng (a world-renowned animal health company) M.cassab (the main veterinary drug trader in Brazil and the exclusive agent of MDAB products in Brazil), Dabinong Group (a large domestic listed feed production company), Chengdu Silai and other customers.